Document is current
Any future updates will be listed below
-
Authors
Bakker, Kevin M. https://orcid.org/0000-0002-7084-9291
Oidtman, Rachel J.
Banniettis, Natalie
Feemster, Kristen https://orcid.org/0000-0003-0822-5688
Velentgas, Priscilla https://orcid.org/0009-0007-4764-2595
Malik, Tufail M. https://orcid.org/0000-0003-0196-0057
Meleleo, Giulio
Weaver, Jessica https://orcid.org/0000-0002-9861-3328
-
Funding
Funding for this research was provided by:
Merck
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 25 February 2025
First Online: 19 March 2025
Declarations
:
: Kevin M. Bakker, Rachel J. Oidtman, Natalie Banniettis, Kristen Feemster, Priscilla Velentgas, Tufail M. Malik, and Jessica Weaver are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and may own restricted stock units and/or stock options in Merck & Co., Inc., Rahway, NJ, USA. Giulio Meleleo is an employee of Wolfram Research, Inc., Champaign, IL, USA. Wolfram Research, Inc., Champaign, IL, USA, received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA for participation in the study.
: As a modeling study using de-identified published data as model inputs, this study was not considered human subjects research and was exempt from human subjects committee review and the need for informed consent. The article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
